STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 95 filers reported holding STOKE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $93,185 | -67.1% | 23,651 | -11.3% | 0.00% | – |
| Q2 2023 | $283,417 | +53.5% | 26,662 | +20.3% | 0.00% | – |
| Q1 2023 | $184,626 | -12.7% | 22,164 | -3.3% | 0.00% | – |
| Q4 2022 | $211,542 | -26.3% | 22,919 | +2.5% | 0.00% | – |
| Q3 2022 | $287,000 | -1.4% | 22,350 | +1.3% | 0.00% | – |
| Q2 2022 | $291,000 | -28.0% | 22,056 | +15.0% | 0.00% | -100.0% |
| Q1 2022 | $404,000 | -20.9% | 19,181 | -10.0% | 0.00% | 0.0% |
| Q4 2021 | $511,000 | -3.6% | 21,313 | +2.3% | 0.00% | 0.0% |
| Q3 2021 | $530,000 | -40.2% | 20,830 | -20.9% | 0.00% | 0.0% |
| Q2 2021 | $887,000 | +11.6% | 26,337 | +28.7% | 0.00% | 0.0% |
| Q1 2021 | $795,000 | -31.6% | 20,463 | +9.1% | 0.00% | -50.0% |
| Q4 2020 | $1,162,000 | +88.3% | 18,764 | +1.9% | 0.00% | +100.0% |
| Q3 2020 | $617,000 | +40.5% | 18,420 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $439,000 | -25.8% | 18,420 | -28.8% | 0.00% | 0.0% |
| Q1 2020 | $592,000 | +46.5% | 25,853 | +81.2% | 0.00% | 0.0% |
| Q4 2019 | $404,000 | +31.6% | 14,264 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $307,000 | – | 14,264 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ATP Life Science Ventures, L.P. | 16,786,713 | $562,187,000 | 75.80% |
| RTW INVESTMENTS, LP | 3,544,248 | $118,697,000 | 2.86% |
| Cormorant Asset Management, LP | 1,537,807 | $51,501,000 | 1.98% |
| Redmile Group, LLC | 2,549,506 | $85,383,000 | 1.57% |
| Birchview Capital, LP | 40,000 | $1,340,000 | 0.45% |
| HighVista Strategies LLC | 17,082 | $572,000 | 0.42% |
| Perceptive Advisors | 671,978 | $22,505,000 | 0.33% |
| GILDER GAGNON HOWE & CO LLC | 1,490,153 | $49,905,000 | 0.31% |
| Artal Group S.A. | 270,750 | $9,067,000 | 0.22% |
| VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 323 | $11,000 | 0.20% |